How Much Does Athira Pharma Inc. (ATHA) Pay Out In Dividends?

As of Wednesday close, Athira Pharma Inc.’s (NASDAQ:ATHA) stock was down -$5.6, moving down -66.27 percent to $2.85. The average number of shares traded per day over the past five days has been 4,643,340 shares. 2 times new highs have been achieved over the past 5 days, with a -$5.18 fall in that time frame. In the last twenty days, the average volume was 1,332,690, while in the previous 50 days, it was 709,228.

Since last month, ATHA stock retreated -68.09%. Shares of the company fell to $2.53 on 06/22/22, the lowest level in the past month. A 52-week high of $16.65 was reached on 04/04/22 after having rallying from a 52-week low of $7.56. Since the beginning of this year, ATHA’s stock price has dropped by -78.13% or -$10.18, and marked a new high 5 times. However, the stock has declined by -82.88% since its 52-week high.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.


Athira Pharma Inc. (ATHA) last reported insider trading activity 84 days ago on Mar 31. Romano Kelly A, the Director of the company, purchased of 8,000 shares for $13.11 on Mar 31. It resulted in a $104,880 investment by the insider.

Financial Health

In the three months ended March 30, Athira Pharma Inc.’s quick ratio stood at 28.40, while its current ratio was 28.40, showing that the company is able to pay off its debt.

While analysts expected Athira Pharma Inc. to report -$0.55 quarterly earnings, the actual figure was -$0.56 per share, beating the consensus estimate by -1.80%. The liabilities of Athira Pharma Inc. were 11.03 million at the end of its most recent quarter ended March 30, and its total debt was $1.85 million. The value of shareholders’ equity is $37.64 million.

Technical Picture

This quick technical analysis looks at Athira Pharma Inc.’s (ATHA) price momentum. With a historical volatility rate of 530.30%, the RSI 9-day stood at 11.51% on 22 June.

With respect to its five-day moving average, the current Athira Pharma Inc. price is down by -64.51% percent or -$5.18. At present, ATHA shares trade -68.44% below its 20-day simple moving average and -71.24% percent below its 100-day simple moving average. However, the stock is currently trading approximately -77.40% below its SMA50 and -73.26% below its SMA200.

Stochastic coefficient K was 24.03% and Stochastic coefficient D was 29.55%, while ATR was 1.15. Given the Stochastic reading of 4.33% for the 14-day period, the RSI (14) reading has been calculated as 16.01%. As of today, the MACD Oscillator reading stands at -1.01, while the 14-day reading stands at -1.55.

Analyst Ratings

BTIG Research launched its rating on Athira Pharma Inc. (NASDAQ: ATHA) to a Buy in a note to investors on May 10, 2022. Athira Pharma Inc. (ATHA) has been rated Overweight by analysts. According to 0 brokerage firms, ATHA is a sell, and 3 firms recommend it is a Hold. There are 0 analysts who say the stock is underweight. A total of 0 analysts rate Athira Pharma Inc. stock as buy, with 3 recommending it as overweight.

With a median target price of $33.00, the current consensus forecast for the stock is $3.00 – $51.00. Based on these forecasts, analysts predict Athira Pharma Inc. (ATHA) will achieve an average price target of $27.83.


Please enter your comment!
Please enter your name here

Hot Topics

Related Articles




Download Free eBook For

The 5 Best Growth Stocks 2022

100% free. stop anytime no spam